Study to Evaluate an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.

- Multiple Sclerosis
- Completed

Study Title: A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtecֲ®) or Placebo Prior to Daily Injections of Copaxoneֲ®.

Teva Identifier: PM014

ClinicalTrials.gov Identifier: NCT00240032

Study Status: Completed

Trial Condition(s): Multiple Sclerosis

Interventions: Drug: glatiramer acetate injection with oral cetirizine hydrochloride | Drug: glatiramer acetate with placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult, Older Adult

Age Range: 18 Years and older

Trial Duration: 10/01/2004 - 07/01/2006

Phase: Phase 4

Study Type

Interventional